Piramal Enterprises has soared 6% to Rs 590 after the company said its board has recommended a dividend of 2625% or Rs 52.50 per equity share of face value of Rs 2/- for the financial year ended March 31, 2014.
Meanwhile, Piramal Enterprises said its March quarter loss has widened to Rs 311 crore from Rs 200 crore in the year-ago period. Its revenue however, rose 30% to Rs 1,107 crore in the three months ended 31 March.
In a separate filing, the company said its board has also approved merger of its subsidiaries --PHL Capital Pvt Ltd, Piramal Pharmaceutical Development Services Pvt Ltd and Oxygen Bio Research Pvt Ltd--with the company.
The stock opened at Rs 573 and touched a high of Rs 599 on the BSE. A combined 260,000 shares changed hands on the counter so far on the BSE and NSE.
Meanwhile, Piramal Enterprises said its March quarter loss has widened to Rs 311 crore from Rs 200 crore in the year-ago period. Its revenue however, rose 30% to Rs 1,107 crore in the three months ended 31 March.
In a separate filing, the company said its board has also approved merger of its subsidiaries --PHL Capital Pvt Ltd, Piramal Pharmaceutical Development Services Pvt Ltd and Oxygen Bio Research Pvt Ltd--with the company.
The stock opened at Rs 573 and touched a high of Rs 599 on the BSE. A combined 260,000 shares changed hands on the counter so far on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%